The linked FDA record identifies Medtronic Navigation as the applicant for K262716, a Special 510(k) for the StealthStation™ S8 Cranial v2.3.0, received July 31, 2026 and decided November 6, 2026 as substantially equivalent. The filing lists a Lafayette, Colorado address, product code HAW, regulation number 882.4560 and the Neurology advisory committee. That address is a correspondence address in the filing, not a verified headquarters. The applicant name is distinct from Medtronic as a corporate brand; the sources do not document a parent-subsidiary relationship beyond the shared name and the Medtronic product page describing the platform. [1][2]

The documented filing

K262716 covers the StealthStation™ S8 Cranial v2.3.0 under product code HAW, device class 2, regulation 882.4560, with the device name recorded as Neurological Stereotaxic Instrument. The decision code is SESE, described as Substantially Equivalent, and the clearance type is Special. The record notes a Summary was prepared and that no third-party review was used. [1]

The supplied portfolio snapshot for this company contains one linked record, a 510(k) with decision SESE, and the sample of one record shows the same SESE decision. These counts describe the supplied filings as of the snapshot date and are not measures of total company sales, total portfolio or safety performance. [1]

Platform features as published

Medtronic's StealthStation™ S8 page states that the system precisely locates anatomical structures in open or percutaneous neurosurgical and spine procedures. The same page describes optical and electromagnetic tracking capabilities, integration with external devices such as microscopes, and a broad array of instruments and core software applications for neurosurgery and spine, listing biopsy among the applications. [2]

The indications page for the StealthStation™ Surgical Navigation System states that the S8 System is intended as an aid for precisely locating anatomical structures in open or percutaneous procedures, and that the system is indicated where stereotactic surgery may be appropriate and a rigid anatomical structure such as the skull, a long bone or a vertebra can be identified relative to a CT- or MR-based model, fluoroscopy images or digitized landmarks. [6]

Earlier clearances and components

An earlier clearance letter for K212397, dated December 22, 2021, covers StealthStation S8 Cranial v2.0 under the same regulation 882.4560, Class II, product code HAW, submitted to Medtronic Navigation at a Louisville, Colorado address. The letter also references an AxiEM III localizer with side and flat emitter types. [3]

Two additional 510(k) database pages for K162309 appear among the sources, but the supplied excerpts show only database navigation text and no device, applicant or decision details, so the subject of that filing is not documented here. [8][9]

Identity and scope limits

The sources support a narrow statement: Medtronic Navigation is the applicant on K262716 for the StealthStation™ S8 Cranial v2.3.0, and Medtronic publishes the StealthStation™ S8 platform as a surgical navigation system for neurosurgery and spine. Ownership structure, headquarters, commercial availability, installed base and clinical performance are not documented in the public information and remain unknown. [1][2][6]